Trial intelligence / Profile preview

Doxycycline for Oral Mucositis Prevention in Acute Leukemia

NCT01087476Phase 2Unknown

Sponsor
Universidad Autónoma Metropolitana
Start
May 2010
Primary completion
Jun 2011
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in oral mucositis (OM) comparing Doxycycline hyclate with Placebo (2 arms). Primary endpoint: Complete Response (No Oral Lesions) at 21 days. Status: unknown.

02

Drugs

doxycycline
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT01087476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01087476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call